4-(7-Methoxy-1-benzofuran-2-yl)-2-(pyridin-4-yl)pyrimidine

Catalog No. :
ACVKTI514
CAS No. :
866131-47-7
Molecular Formula :
C18H13N3O2
Molecular Weight :
303.32

IUPAC Name:4-(7-methoxybenzofuran-2-yl)-2-(pyridin-4-yl)pyrimidine

4-(7-Methoxy-1-benzofuran-2-yl)-2-(pyridin-4-yl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(7-Methoxy-1-benzofuran-2-yl)-2-(pyridin-4-yl)pyrimidine
IUPAC Name4-(7-methoxybenzofuran-2-yl)-2-(pyridin-4-yl)pyrimidine
MDL No.MFCD03617710
Molecular FormulaC18H13N3O2
Molecular Weight303.32
SMILESCOC1=C(OC(C2=NC(C3=CC=NC=C3)=NC=C2)=C4)C4=CC=C1
InChI KeyUATYZUGZEQATTQ-UHFFFAOYSA-N
Synonym4-(7-METHOXY-1-BENZOFURAN-2-YL)-2-(4-PYRIDINYL)PYRIMIDINE;METHYL 2-[2-(4-PYRIDINYL)-4-PYRIMIDINYL]-1-BENZOFURAN-7-YL ETHER;4-(7-methoxy-1-benzofuran-2-yl)-2-(pyridin-4-yl)pyrimidine;Pyrimidine, 4-(7-methoxy-2-benzofuranyl)-2-(4-pyridinyl)-
CAS No.866131-47-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVKTI514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1 In Stock
  4. Then
  5. ACVKTI514 route product structure diagram
    ACVKTI514866131-47-7
Inquiry

2. ACVKTI514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVKTI514 route product structure diagram
    ACVKTI514866131-47-7
Inquiry

Comments (0)